FDA Amends Animal Drug Regulations to Reflect Cross Vetpharm Approval

Summary

The FDA is updating its animal drug regulations to reflect the approval of a supplemental new animal drug application for Cross Vetpharm Group Ltd.'s injectable penicillin suspension, which includes a warning against using the product in calves destined for veal production. The FDA is also clarifying approved indications for several penicillin products to improve the accuracy of the regulations.